Ｍ－サイバダイン－議：Marketing clearance from U.S. FDA for Medical HAL expands to stroke and progressive neuromuscular disease - 有報キャッチャー

Ｍ－サイバダイン－議（7779）　Marketing clearance from U.S. FDA for Medical HAL expands to stroke and progressive neuromuscular disease 2020/10/06

/-

読み込み中…